Exact Mass: 402.361

Exact Mass Matches: 402.361

Found 25 metabolites which its exact mass value is equals to given mass value 402.361, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Saracodine

N-[1-[3-(dimethylamino)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-N-methylacetamide

C26H46N2O (402.361)


   

Cyclovirobuxine D

7,7,12,16-tetramethyl-6-(methylamino)-15-[1-(methylamino)ethyl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol

C26H46N2O (402.361)


   

CVB-D

(1S,3R,6S,8R,11S,12S,14R,15S,16R)-7,7,12,16-tetramethyl-6-(methylamino)-15-[(1S)-1-(methylamino)ethyl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-14-ol

C26H46N2O (402.361)


Cyclovirobuxine D is a natural product found in Buxus microphylla and Buxus sempervirens with data available. Cyclovirobuxine D (CVB-D) is the main active component of the traditional Chinese medicine Buxus microphylla. Cyclovirobuxine D induces autophagy and attenuates the phosphorylation of Akt and mTOR[1]. Cyclovirobuxine D inhibits cell proliferation of gastric cancer cells through suppression of cell cycle progression and inducement of mitochondria-mediated apoptosis[2]. Cyclovirobuxine D is beneficial for heart failure induced by myocardial infarction[3]. Cyclovirobuxine D (CVB-D) is the main active component of the traditional Chinese medicine Buxus microphylla. Cyclovirobuxine D induces autophagy and attenuates the phosphorylation of Akt and mTOR[1]. Cyclovirobuxine D inhibits cell proliferation of gastric cancer cells through suppression of cell cycle progression and inducement of mitochondria-mediated apoptosis[2]. Cyclovirobuxine D is beneficial for heart failure induced by myocardial infarction[3].

   

Cyclopapilosine D

Cyclopapilosine D

C26H46N2O (402.361)


   

Cyclovirobuxine

Cyclovirobuxine

C26H46N2O (402.361)


   
   

SCHEMBL2694371

SCHEMBL2694371

C24H50O4 (402.3709)


   

c18e3

Triethylene glycol monooctadecyl ether

C24H50O4 (402.3709)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Structure is C18EO2 - spectrum includes x>2; Digitised from figure: approximate intensities

   

N-5Z,8Z,11Z,14Z-eicosatetraenoyl-N-diethyl-ethylenediamine

N-5Z,8Z,11Z,14Z-eicosatetraenoyl-N-diethyl-ethylenediamine

C26H46N2O (402.361)


   

N-arachidonoyl-N-diethylethylenediamine

N-5Z,8Z,11Z,14Z-eicosatetraenoyl-N-diethyl-ethylenediamine

C26H46N2O (402.361)


   

MG O-21:0;O

1-O-(2R-hydroxy-heneicosanyl)-sn-glycerol

C24H50O4 (402.3709)


   

Acetamide, N-(3-beta-(dimethylamino)-5-alpha-pregnan-20-alpha-yl)-N-me thyl-

Acetamide, N-(3-beta-(dimethylamino)-5-alpha-pregnan-20-alpha-yl)-N-me thyl-

C26H46N2O (402.361)


   

1-O-(2R-hydroxy-heneicosanyl)-sn-glycerol

1-O-(2R-hydroxy-heneicosanyl)-sn-glycerol

C24H50O4 (402.3709)


   

NA-Putrescine 22:4(7Z,10Z,13Z,16Z)

NA-Putrescine 22:4(7Z,10Z,13Z,16Z)

C26H46N2O (402.361)


   

n-[(1r)-1-[(1s,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

n-[(1r)-1-[(1s,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

C26H46N2O (402.361)


   

n-[(1r)-1-[(1s,3as,3br,5as,7r,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

n-[(1r)-1-[(1s,3as,3br,5as,7r,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

C26H46N2O (402.361)


   

n-{1-[7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl}-n-methylacetamide

n-{1-[7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl}-n-methylacetamide

C26H46N2O (402.361)


   

n-[(1s)-1-[(1s,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

n-[(1s)-1-[(1s,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

C26H46N2O (402.361)


   

n-{1-[(3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl}-n-methylacetamide

n-{1-[(3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl}-n-methylacetamide

C26H46N2O (402.361)


   

n-[(1s)-1-[(1s,3as,3br,5as,7r,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

n-[(1s)-1-[(1s,3as,3br,5as,7r,9as,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

C26H46N2O (402.361)


   

(1r,3s,6s,8r,11s,12s,14r,15s,16r)-7,7,12,16-tetramethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol

(1r,3s,6s,8r,11s,12s,14r,15s,16r)-7,7,12,16-tetramethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol

C26H46N2O (402.361)


   

n-[(1r)-1-[(1s,3as,3br,5as,7r,9as,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

n-[(1r)-1-[(1s,3as,3br,5as,7r,9as,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide

C26H46N2O (402.361)


   

(1s)-1-{[(1r)-1-hydroxydodecyl]peroxy}dodecan-1-ol

(1s)-1-{[(1r)-1-hydroxydodecyl]peroxy}dodecan-1-ol

C24H50O4 (402.3709)


   

1-[(1-hydroxydodecyl)peroxy]dodecan-1-ol

1-[(1-hydroxydodecyl)peroxy]dodecan-1-ol

C24H50O4 (402.3709)


   

n-[(1s,3as,3br,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-n-methylacetamide

n-[(1s,3as,3br,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-n-methylacetamide

C26H46N2O (402.361)